Organization and Description of Business (Details) $ in Thousands |
3 Months Ended | |
|---|---|---|
|
Mar. 31, 2025
USD ($)
segment
medicine
|
Dec. 31, 2024
USD ($)
|
|
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
| Date of incorporation | May 02, 2018 | |
| Number of approved medicines | medicine | 3 | |
| Number of operating segments | segment | 1 | |
| Accumulated deficit | $ (658,858) | $ (644,181) |
| Unrestricted cash, cash equivalents and investments | $ 298,600 |
| X | ||||||||||
- Definition Date when an entity was incorporated No definition available.
|
| X | ||||||||||
- Definition Number of Approved Medicines No definition available.
|
| X | ||||||||||
- Definition Sum of investments and unrestricted cash as of the balance sheet date. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of accumulated undistributed earnings (deficit). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|